Barbara Daly, PhD, RN, from the Case Western Reserve University, discusses the feasibility of establishing a psychosocial data registry for patients with cancer.
Barbara Daly, PhD, RN, Professor, Frances Payne Bolton School of Nursing, Case Western Reserve University, discusses the feasibility of establishing a psychosocial data registry for patients with cancer.
For nurses, the quality of life and psychosocial challenges of a cancer diagnosis and treatment are particularly important. Preliminarily, Daly notes being surprising that many cancer centers have tumor registries that record histologic data but none recorded detailed information on quality of life. To examine this further, a study on the feasibility of setting up a psychosocial registry was undertaken.
The study found that a majority of patients with newly diagnosed cancer were willing to participate in a registry. Additionally, many of the patients agreed to being contacted in the future for additional studies. The registry gathered data on psychological, social, emotional, and spiritual aspects of quality of life for both patients and family caregivers. Daly believes this provides reliable data for future trials, with the potential of establishing a national psychosocial data registry.
Oncology Nurses Provide Patients an Avenue to Supportive CareNovember 12th 2019
Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Impact of Goals of Care on Resource Use at End of LifeSeptember 13th 2018
Researchers exam­ined whether there were differences in resource use at end of life between patients with advanced cancer who identified goals of care focused heavily upon survival versus those who identified goals of care heavily focused on quality of life.
TROPiCS-02 Final OS Analysis Shows Superior Outcomes With Sacituzumab Govitecan For HR+/HER2– Breast Cancer
Cilta-cel Showcases PFS Improvement Following First Relapse In Lenalidomide-Refractory Myeloma
Meredith Cummings on Using Machine Learning to Predict Treatment-Related Adverse Events
Cancer Vaccine mRNA-4157 Improves Recurrence-Free Survival for Patients With High-Risk Melanoma
2 Clarke Drive
Cranbury, NJ 08512